Insider Purchase Sparks Rally in Pelthos Therapeutics Shares
Pelthos Therapeutics shares climbed after a Form 4 filing showed director Todd C. Davis bought about 35,948 shares for nearly $1 million on June 11, 2026. The filing, made public June 15, revealed weighted average purchase prices between about $27.80 and $28.73. The insider transaction, Davis' second-largest of six purchases, coincided with a favor…